Copyright Reports & Markets. All rights reserved.

Global Drug-Eluting Stent Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Drug-Eluting Stent

      • 1.1 Definition of Drug-Eluting Stent
      • 1.2 Drug-Eluting Stent Segment by Type
        • 1.2.1 Global Drug-Eluting Stent Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 ZES-BP
        • 1.2.3 EES
        • 1.2.4 ZES
        • 1.2.5 SES
        • 1.2.6 PES
      • 1.3 Drug-Eluting Stent Segment by Applications
        • 1.3.1 Global Drug-Eluting Stent Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Cath labs
        • 1.3.3 Hospitals
        • 1.3.4 Ambulatory surgical centers (ASCs)
      • 1.4 Global Drug-Eluting Stent Overall Market
        • 1.4.1 Global Drug-Eluting Stent Revenue (2014-2025)
        • 1.4.2 Global Drug-Eluting Stent Production (2014-2025)
        • 1.4.3 North America Drug-Eluting Stent Status and Prospect (2014-2025)
        • 1.4.4 Europe Drug-Eluting Stent Status and Prospect (2014-2025)
        • 1.4.5 China Drug-Eluting Stent Status and Prospect (2014-2025)
        • 1.4.6 Japan Drug-Eluting Stent Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Drug-Eluting Stent Status and Prospect (2014-2025)
        • 1.4.8 India Drug-Eluting Stent Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Drug-Eluting Stent
      • 2.3 Manufacturing Process Analysis of Drug-Eluting Stent
      • 2.4 Industry Chain Structure of Drug-Eluting Stent

      3 Development and Manufacturing Plants Analysis of Drug-Eluting Stent

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Drug-Eluting Stent Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Drug-Eluting Stent
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Drug-Eluting Stent Production and Capacity Analysis
      • 4.2 Drug-Eluting Stent Revenue Analysis
      • 4.3 Drug-Eluting Stent Price Analysis
      • 4.4 Market Concentration Degree

      5 Drug-Eluting Stent Regional Market Analysis

      • 5.1 Drug-Eluting Stent Production by Regions
        • 5.1.1 Global Drug-Eluting Stent Production by Regions
        • 5.1.2 Global Drug-Eluting Stent Revenue by Regions
      • 5.2 Drug-Eluting Stent Consumption by Regions
      • 5.3 North America Drug-Eluting Stent Market Analysis
        • 5.3.1 North America Drug-Eluting Stent Production
        • 5.3.2 North America Drug-Eluting Stent Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Drug-Eluting Stent Import and Export
      • 5.4 Europe Drug-Eluting Stent Market Analysis
        • 5.4.1 Europe Drug-Eluting Stent Production
        • 5.4.2 Europe Drug-Eluting Stent Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Drug-Eluting Stent Import and Export
      • 5.5 China Drug-Eluting Stent Market Analysis
        • 5.5.1 China Drug-Eluting Stent Production
        • 5.5.2 China Drug-Eluting Stent Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Drug-Eluting Stent Import and Export
      • 5.6 Japan Drug-Eluting Stent Market Analysis
        • 5.6.1 Japan Drug-Eluting Stent Production
        • 5.6.2 Japan Drug-Eluting Stent Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Drug-Eluting Stent Import and Export
      • 5.7 Southeast Asia Drug-Eluting Stent Market Analysis
        • 5.7.1 Southeast Asia Drug-Eluting Stent Production
        • 5.7.2 Southeast Asia Drug-Eluting Stent Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Drug-Eluting Stent Import and Export
      • 5.8 India Drug-Eluting Stent Market Analysis
        • 5.8.1 India Drug-Eluting Stent Production
        • 5.8.2 India Drug-Eluting Stent Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Drug-Eluting Stent Import and Export

      6 Drug-Eluting Stent Segment Market Analysis (by Type)

      • 6.1 Global Drug-Eluting Stent Production by Type
      • 6.2 Global Drug-Eluting Stent Revenue by Type
      • 6.3 Drug-Eluting Stent Price by Type

      7 Drug-Eluting Stent Segment Market Analysis (by Application)

      • 7.1 Global Drug-Eluting Stent Consumption by Application
      • 7.2 Global Drug-Eluting Stent Consumption Market Share by Application (2014-2019)

      8 Drug-Eluting Stent Major Manufacturers Analysis

      • 8.1 Abbott Laboratories
        • 8.1.1 Abbott Laboratories Drug-Eluting Stent Production Sites and Area Served
        • 8.1.2 Abbott Laboratories Product Introduction, Application and Specification
        • 8.1.3 Abbott Laboratories Drug-Eluting Stent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Biosensors International Group
        • 8.2.1 Biosensors International Group Drug-Eluting Stent Production Sites and Area Served
        • 8.2.2 Biosensors International Group Product Introduction, Application and Specification
        • 8.2.3 Biosensors International Group Drug-Eluting Stent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Boston Scientific
        • 8.3.1 Boston Scientific Drug-Eluting Stent Production Sites and Area Served
        • 8.3.2 Boston Scientific Product Introduction, Application and Specification
        • 8.3.3 Boston Scientific Drug-Eluting Stent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Medtronic
        • 8.4.1 Medtronic Drug-Eluting Stent Production Sites and Area Served
        • 8.4.2 Medtronic Product Introduction, Application and Specification
        • 8.4.3 Medtronic Drug-Eluting Stent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Terumo Corporation
        • 8.5.1 Terumo Corporation Drug-Eluting Stent Production Sites and Area Served
        • 8.5.2 Terumo Corporation Product Introduction, Application and Specification
        • 8.5.3 Terumo Corporation Drug-Eluting Stent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Biotronik
        • 8.6.1 Biotronik Drug-Eluting Stent Production Sites and Area Served
        • 8.6.2 Biotronik Product Introduction, Application and Specification
        • 8.6.3 Biotronik Drug-Eluting Stent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Cook Medical
        • 8.7.1 Cook Medical Drug-Eluting Stent Production Sites and Area Served
        • 8.7.2 Cook Medical Product Introduction, Application and Specification
        • 8.7.3 Cook Medical Drug-Eluting Stent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Envision Scientific
        • 8.8.1 Envision Scientific Drug-Eluting Stent Production Sites and Area Served
        • 8.8.2 Envision Scientific Product Introduction, Application and Specification
        • 8.8.3 Envision Scientific Drug-Eluting Stent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Lepu Medical
        • 8.9.1 Lepu Medical Drug-Eluting Stent Production Sites and Area Served
        • 8.9.2 Lepu Medical Product Introduction, Application and Specification
        • 8.9.3 Lepu Medical Drug-Eluting Stent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Meril Life Sciences
        • 8.10.1 Meril Life Sciences Drug-Eluting Stent Production Sites and Area Served
        • 8.10.2 Meril Life Sciences Product Introduction, Application and Specification
        • 8.10.3 Meril Life Sciences Drug-Eluting Stent Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 MicroPort Medical
      • 8.12 Opto Circuits
      • 8.13 Shandong JW Medical Systems
      • 8.14 STENTYS

      9 Development Trend of Analysis of Drug-Eluting Stent Market

      • 9.1 Global Drug-Eluting Stent Market Trend Analysis
        • 9.1.1 Global Drug-Eluting Stent Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Drug-Eluting Stent Regional Market Trend
        • 9.2.1 North America Drug-Eluting Stent Forecast 2019-2025
        • 9.2.2 Europe Drug-Eluting Stent Forecast 2019-2025
        • 9.2.3 China Drug-Eluting Stent Forecast 2019-2025
        • 9.2.4 Japan Drug-Eluting Stent Forecast 2019-2025
        • 9.2.5 Southeast Asia Drug-Eluting Stent Forecast 2019-2025
        • 9.2.6 India Drug-Eluting Stent Forecast 2019-2025
      • 9.3 Drug-Eluting Stent Market Trend (Product Type)
      • 9.4 Drug-Eluting Stent Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Drug-Eluting Stent Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Drug-eluting stents, also known as medicated coronary stents, are used to inhibit artery blockages that may occur in patients after an angioplasty surgery. A drug-eluting stent is a tiny, expandable metal mesh tube, which is covered with a pharmacologic agent (drug). Drug-eluting stents are used to treat patients that suffer from atherosclerosis that can occur because of hypertension, smoking, a sedentary lifestyle, or a high-cholesterol diet. After a patient undergoes angioplasty, there is a chance that the artery might close again because of blood clots or excessive growth of the surrounding tissues. To address this problem, drug-eluting stents are placed in the artery, preventing it from narrowing or clogging. Thus, drug-eluting stents eliminate the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels). Restenosis of an artery occurs because of the body’s natural immune response to an injury. Drug-eluting stents help in reducing the arterial blockage and ensure smooth blood flow through the arteries.
        The growing prevalence of these diseases is due to factors such as smoking, obesity, alcohol consumption, and unhealthy lifestyle. Furthermore, the rapidly increasing older population is driving the market because aging increase the chances of developing cardiovascular diseases including atherosclerosis.
        The global market for the drug-eluting stent is highly fragmented due to the presence of several well-established vendors. The competition is expected to intensify with an increase in product portfolio extensions with next-generation products, technological innovations, and mergers and acquisitions.

        The global Drug-Eluting Stent market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Drug-Eluting Stent volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drug-Eluting Stent market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Drug-Eluting Stent in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Drug-Eluting Stent manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Abbott Laboratories
        Biosensors International Group
        Boston Scientific
        Medtronic
        Terumo Corporation
        Biotronik
        Cook Medical
        Envision Scientific
        Lepu Medical
        Meril Life Sciences
        MicroPort Medical
        Opto Circuits
        Shandong JW Medical Systems
        STENTYS

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        ZES-BP
        EES
        ZES
        SES
        PES

        Segment by Application
        Cath labs
        Hospitals
        Ambulatory surgical centers (ASCs)

        Buy now